ADME properties evaluation in drug discovery: in silico prediction of blood–brain partitioning

The absorption, distribution, metabolism and excretion properties are important for drugs, and prediction of these properties in advance will save the cost of drug discovery substantially. The ability to penetrate the blood–brain barrier is critical for drugs targeting central nervous system, which is represented by the ratio of its concentration in brain and in blood. Herein, a quantitative structure–property relationship study was carried out to predict blood–brain partitioning coefficient (logBB) of a data set consisting of 287 compounds. Four different methods including support vector machine, multivariate linear regression, multivariate adaptive regression splines and random forest were employed to build prediction models with 116 molecular descriptors selected by Boruta algorithm. The RF model had best performance in training set ($$ R^{2} $$R2 = 0.938), test set ($$ R^{2} $$R2 = 0.840) and tenfold cross-validation ($$ Q^{2} $$Q2 = 0.788). Finally, we found that the polar surface area and octanol–water partition coefficient have the greatest influence on blood–brain partitioning. Results suggest that the proposed model is a useful and practical tool to predict the logBB values of drug candidates.

[1]  Junmei Wang,et al.  Applications of genetic algorithms on the structure–activity correlation study of a group of non-nucleoside HIV-1 inhibitors , 1999 .

[2]  Alexander Golbraikh,et al.  QSAR Modeling of the Blood–Brain Barrier Permeability for Diverse Organic Compounds , 2008, Pharmaceutical Research.

[3]  Ramamurthi Narayanan,et al.  In silico ADME modelling: prediction models for blood-brain barrier permeation using a systematic variable selection method. , 2005, Bioorganic & medicinal chemistry.

[4]  M. Jalali-Heravi,et al.  Quantitative structure-activity relationship study of serotonin (5-HT7) receptor inhibitors using modified ant colony algorithm and adaptive neuro-fuzzy interference system (ANFIS). , 2009, European journal of medicinal chemistry.

[5]  Jahan B Ghasemi,et al.  Application of principal component analysis-multivariate adaptive regression splines for the simultaneous spectrofluorimetric determination of dialkyltins in micellar media. , 2013, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[6]  Scott D. Kahn,et al.  Current Status of Methods for Defining the Applicability Domain of (Quantitative) Structure-Activity Relationships , 2005, Alternatives to laboratory animals : ATLA.

[7]  Miguel A. Cabrera,et al.  TOPS-MODE approach for the prediction of blood-brain barrier permeation. , 2004, Journal of pharmaceutical sciences.

[8]  M. Kansy,et al.  Hydrogen-Bonding Capacity and Brain Penetration , 1992, Chimia (Basel).

[9]  Denis M. Bayada,et al.  Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs , 1999, Pharmaceutical Research.

[10]  Liping Lu,et al.  Effects of triazole fungicides on androgenic disruption and CYP3A4 enzyme activity. , 2017, Environmental pollution.

[11]  Franco Lombardo,et al.  A recursive-partitioning model for blood–brain barrier permeation , 2005, J. Comput. Aided Mol. Des..

[12]  Hongmao Sun,et al.  A Universal Molecular Descriptor System for Prediction of LogP, LogS, LogBB, and Absorption , 2004, J. Chem. Inf. Model..

[13]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[14]  C. Fong Statins in therapy: understanding their hydrophilicity, lipophilicity, binding to 3-hydroxy-3-methylglutaryl-CoA reductase, ability to cross the blood brain barrier and metabolic stability based on electrostatic molecular orbital studies. , 2014, European journal of medicinal chemistry.

[15]  U Norinder,et al.  Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics. , 1998, Journal of pharmaceutical sciences.

[16]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[17]  Paola Gramatica,et al.  Principles of QSAR models validation: internal and external , 2007 .

[18]  Roberto Kawakami Harrop Galvão,et al.  A method for calibration and validation subset partitioning. , 2005, Talanta.

[19]  Maria G. Kouskoura,et al.  A new descriptor via bio‐mimetic chromatography and modeling for the blood brain barrier (Part II) , 2019, Journal of pharmaceutical and biomedical analysis.

[20]  Alexander Tropsha,et al.  Best Practices for QSAR Model Development, Validation, and Exploitation , 2010, Molecular informatics.

[21]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[22]  Bernard Testa,et al.  A simple model to predict blood-brain barrier permeation from 3D molecular fields. , 2002, Biochimica et biophysica acta.

[23]  S. Walker,et al.  Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). , 1988, British journal of clinical pharmacology.

[24]  D. E. Clark,et al.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.

[25]  R. Kaliszan,et al.  Partial least square and hierarchical clustering in ADMET modeling: prediction of blood-brain barrier permeation of α-adrenergic and imidazoline receptor ligands. , 2013, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[26]  P. Selzer,et al.  Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. , 2000, Journal of medicinal chemistry.

[27]  Tian-Shyug Lee,et al.  Mining the customer credit using classification and regression tree and multivariate adaptive regression splines , 2006, Comput. Stat. Data Anal..

[28]  Alexandre Varnek,et al.  Correlation of blood-brain penetration using structural descriptors. , 2006, Bioorganic & medicinal chemistry.

[29]  X. J. Xu,et al.  ADME Evaluation in Drug Discovery. Part 3. Modeling Blood‐Brain Barrier Partitioning Using Simple Molecular Descriptors. , 2004 .

[30]  Qingjun Liu,et al.  Interactions of benzotriazole UV stabilizers with human serum albumin: Atomic insights revealed by biosensors, spectroscopies and molecular dynamics simulations. , 2016, Chemosphere.

[31]  P. Gross,et al.  Sensory circumventricular organs and brain homeostatic pathways , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  C. Fong Permeability of the Blood–Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds , 2015, The Journal of Membrane Biology.

[33]  Yizeng Liang,et al.  Exploring nonlinear relationships in chemical data using kernel-based methods , 2011 .

[34]  Prabha Garg,et al.  In Silico Prediction of Blood Brain Barrier Permeability: An Artificial Neural Network Model , 2006, J. Chem. Inf. Model..

[35]  Witold R. Rudnicki,et al.  Feature Selection with the Boruta Package , 2010 .

[36]  Yvan Vander Heyden,et al.  Benchmarking of QSAR Models for Blood-Brain Barrier Permeation , 2007, J. Chem. Inf. Model..

[37]  Matheus Malta de Sá,et al.  A 2D-QSPR approach to predict blood-brain barrier penetration of drugs acting on the central nervous system , 2010 .

[38]  A. Ghose,et al.  Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods , 1998 .

[39]  Chunlong Zhang,et al.  Benzotriazole UV 328 and UV-P showed distinct antiandrogenic activity upon human CYP3A4-mediated biotransformation. , 2017, Environmental pollution.

[40]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors , 2003, J. Chem. Inf. Comput. Sci..

[41]  James W. McFarland,et al.  Quantitative Estimation of Drug Absorption in Humans for Passively Transported Compounds on the Basis of Their Physico‐chemical Parameters , 2000 .

[42]  Klaus-Robert Müller,et al.  Estimating the domain of applicability for machine learning QSAR models: a study on aqueous solubility of drug discovery molecules , 2007, J. Comput. Aided Mol. Des..

[43]  S Agatonovic-Kustrin,et al.  Theoretically-derived molecular descriptors important in human intestinal absorption. , 2001, Journal of pharmaceutical and biomedical analysis.

[44]  Márcia M. C. Ferreira,et al.  Basic validation procedures for regression models in QSAR and QSPR studies: theory and application , 2009 .

[45]  Shulin Zhuang,et al.  Side Chains of Parabens Modulate Antiandrogenic Activity: In Vitro and Molecular Docking Studies. , 2017, Environmental science & technology.

[46]  M. Abraham,et al.  A data base for partition of volatile organic compounds and drugs from blood/plasma/serum to brain, and an LFER analysis of the data. , 2006, Journal of pharmaceutical sciences.

[47]  S. Hirono,et al.  Simple Method of Calculating Octanol/Water Partition Coefficient. , 1992 .

[48]  Thomas Dandekar,et al.  Analysing molecular polar surface descriptors to predict blood-brain barrier permeation , 2013, Int. J. Comput. Biol. Drug Des..

[49]  Harpreet S. Chadha,et al.  Hydrogen-bonding. Part 36. Determination of blood brain distribution using octanol-water partition coefficients. , 1995, Drug design and discovery.